TABLE OF CONTENTS
|  |  |  | Volume 33, Issue 47 (November 2014) |  | In this issue Review Original Articles Short Communication
Also new    AOP | |  |  | Review | Top |  | Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAFV600E or wild-type BRAFZ A Antonello and C Nucera Oncogene 2014 33: 5397-5404; advance online publication, December 23, 2013; 10.1038/onc.2013.544 Abstract | Full Text |  | Original Articles | Top |  | Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapyW Leconet, C Larbouret, T Chardès, G Thomas, M Neiveyans, M Busson, M Jarlier, N Radosevic-Robin, M Pugnière, F Bernex, F Penault-Llorca, J-M Pasquet, A Pèlegrin and B Robert Oncogene 2014 33: 5405-5414; advance online publication, November 18, 2013; 10.1038/onc.2013.487 Abstract | Full Text |  |  |  | The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphomaA Newbold, J M Salmon, B P Martin, K Stanley and R W Johnstone Oncogene 2014 33: 5415-5423; advance online publication, December 2, 2013; 10.1038/onc.2013.482 Abstract | Full Text |  |  |  | FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damageS Yan, L Qiu, K Ma, X Zhang, Y Zhao, J Zhang, X Li, X Hao and Z Li Oncogene 2014 33: 5424-5433; advance online publication, November 18, 2013; 10.1038/onc.2013.494 Abstract | Full Text |  |  |  | Novel fusion transcripts in human gastric cancer revealed by transcriptome analysisH-P Kim, G-A Cho, S-W Han, J-Y Shin, E-G Jeong, S-H Song, W-C Lee, K-H Lee, D Bang, J-S Seo, J-Il Kim and T-Y Kim Oncogene 2014 33: 5434-5441; advance online publication, November 18, 2013; 10.1038/onc.2013.490 Abstract | Full Text |  |  |  | Transformation by HrasG12V is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibitionX Chen, J M Makarewicz, J A Knauf, L K Johnson and J A Fagin Oncogene 2014 33: 5442-5449; advance online publication, November 18, 2013; 10.1038/onc.2013.489 Abstract | Full Text |  |  |  | Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancerW A Hall, A V Petrova, L E Colbert, C W Hardy, S B Fisher, B Saka, J W Shelton, M D Warren, B G Pantazides, K Gandhi, J Kowalski, D A Kooby, B F El-Rayes, C A Staley, 3rd, N Volkan Adsay, W J Curran, J C Landry, S K Maithel and D S Yu Oncogene 2014 33: 5450-5456; advance online publication, November 25, 2013; 10.1038/onc.2013.488 Abstract | Full Text |  |  |  | Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cellsE Zaganjor, J K Osborne, L M Weil, L A Diaz-Martinez, J X Gonzales, S M Singel, J E Larsen, L Girard, J D Minna and M H Cobb Oncogene 2014 33: 5457-5466; advance online publication, November 18, 2013; 10.1038/onc.2013.486 Abstract | Full Text |  |  |  | Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effectsS Bhattacharyya, L Feferman and J K Tobacman Oncogene 2014 33: 5467-5476; advance online publication, November 18, 2013; 10.1038/onc.2013.483 Abstract | Full Text |  | Short Communication | Top |  | A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancerA Vassilopoulos, C Chisholm, T Lahusen, H Zheng and C-X Deng Oncogene 2014 33: 5477-5482; advance online publication, December 9, 2013; 10.1038/onc.2013.516 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
No comments:
Post a Comment